20-46043241-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020708.5(SLC12A5):​c.1155C>T​(p.Ile385Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0277 in 1,613,964 control chromosomes in the GnomAD database, including 1,179 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 170 hom., cov: 31)
Exomes 𝑓: 0.028 ( 1009 hom. )

Consequence

SLC12A5
NM_020708.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.19

Publications

8 publications found
Variant links:
Genes affected
SLC12A5 (HGNC:13818): (solute carrier family 12 member 5) K-Cl cotransporters are proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The protein encoded by this gene is an integral membrane K-Cl cotransporter that can function in either a net efflux or influx pathway, depending on the chemical concentration gradients of potassium and chloride. The encoded protein can act as a homomultimer, or as a heteromultimer with other K-Cl cotransporters, to maintain chloride homeostasis in neurons. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Sep 2008]
SLC12A5 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 34
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • epilepsy of infancy with migrating focal seizures
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 14
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 20-46043241-C-T is Benign according to our data. Variant chr20-46043241-C-T is described in ClinVar as Benign. ClinVar VariationId is 475640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A5NM_020708.5 linkc.1155C>T p.Ile385Ile synonymous_variant Exon 9 of 26 ENST00000243964.7 NP_065759.1 Q9H2X9-2
SLC12A5NM_001134771.2 linkc.1224C>T p.Ile408Ile synonymous_variant Exon 9 of 26 NP_001128243.1 Q9H2X9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A5ENST00000243964.7 linkc.1155C>T p.Ile385Ile synonymous_variant Exon 9 of 26 1 NM_020708.5 ENSP00000243964.4 Q9H2X9-2

Frequencies

GnomAD3 genomes
AF:
0.0290
AC:
4405
AN:
151982
Hom.:
167
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00800
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.117
Gnomad ASJ
AF:
0.0539
Gnomad EAS
AF:
0.0276
Gnomad SAS
AF:
0.0271
Gnomad FIN
AF:
0.0183
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0225
Gnomad OTH
AF:
0.0336
GnomAD2 exomes
AF:
0.0413
AC:
10375
AN:
251420
AF XY:
0.0372
show subpopulations
Gnomad AFR exome
AF:
0.00572
Gnomad AMR exome
AF:
0.149
Gnomad ASJ exome
AF:
0.0511
Gnomad EAS exome
AF:
0.0292
Gnomad FIN exome
AF:
0.0217
Gnomad NFE exome
AF:
0.0215
Gnomad OTH exome
AF:
0.0393
GnomAD4 exome
AF:
0.0276
AC:
40291
AN:
1461864
Hom.:
1009
Cov.:
32
AF XY:
0.0273
AC XY:
19824
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00511
AC:
171
AN:
33480
American (AMR)
AF:
0.149
AC:
6641
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0528
AC:
1381
AN:
26136
East Asian (EAS)
AF:
0.0347
AC:
1377
AN:
39700
South Asian (SAS)
AF:
0.0300
AC:
2590
AN:
86258
European-Finnish (FIN)
AF:
0.0194
AC:
1034
AN:
53420
Middle Eastern (MID)
AF:
0.0154
AC:
89
AN:
5768
European-Non Finnish (NFE)
AF:
0.0227
AC:
25208
AN:
1111988
Other (OTH)
AF:
0.0298
AC:
1800
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2118
4237
6355
8474
10592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1064
2128
3192
4256
5320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0290
AC:
4410
AN:
152100
Hom.:
170
Cov.:
31
AF XY:
0.0309
AC XY:
2294
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00798
AC:
331
AN:
41504
American (AMR)
AF:
0.117
AC:
1789
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0539
AC:
187
AN:
3470
East Asian (EAS)
AF:
0.0275
AC:
142
AN:
5166
South Asian (SAS)
AF:
0.0271
AC:
130
AN:
4800
European-Finnish (FIN)
AF:
0.0183
AC:
194
AN:
10600
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0225
AC:
1527
AN:
67982
Other (OTH)
AF:
0.0342
AC:
72
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
202
404
606
808
1010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0245
Hom.:
57
Bravo
AF:
0.0347
Asia WGS
AF:
0.0270
AC:
94
AN:
3478
EpiCase
AF:
0.0233
EpiControl
AF:
0.0247

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 21. Only high quality variants are reported. -

Developmental and epileptic encephalopathy, 34 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
2.3
DANN
Benign
0.52
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35804246; hg19: chr20-44671880; API